ザフェル・ギュルバシュ教授（医学博士）は、ホジキンリンパ腫に対して900件以上の治療を実施し、アナドル病院に骨髄移植センターを設立しました。
ビュレント・カラゴズ博士は腫瘍生物学と免疫療法を専門とし、アナドル医療センターにおけるホジキンリンパ腫治療において33年の経験にわたる集中的な専門知識を有しています。
, India
Dr. K.K. Iswaran is a reputed and experienced Obstetrician and Gynaecologist with more than 25 years of experience in his field. His key takeaways include:
ロン・ラム医師は、内科、血液学、医療腫瘍学の認定医です。彼のプロフェッショナルな旅は、ニューヨーク州立大学ブルックリン校でのレジデンシーと、ニューヨーク医科大学ウェストチェスター医療センターでの血液学と腫瘍学のフェローシップを含みます。医学分野への彼の献身は、30以上の科学論文と医学教科書の1章を含む広範な学術的貢献を通じて示されています。さらに、彼は数百件の幹細胞移植を行い、この分野での彼の専門性を強調しています。
Ronit El Hasid is the Head of Pediatric Oncohematology and Oncology at Dana Dwek Children's Hospital. She specializes in bone marrow and umbilical blood transplantation for pediatric patients. Dr. El Hasid has conducted over 300 successful transplantations. This volume of procedures provides her with deep clinical insight into complex hematologic cases.
The doctor treats children with blood disorders and various forms of pediatric cancer. She uses high-precision procedures and therapies to improve patient outcomes. Her clinical focus includes:
Dr. El Hasid treats a wide range of hematologic and oncologic conditions, including:
Dr. El Hasid leads the Department of Pediatric Oncohematology and Oncology at Dana Dwek Children's Hospital. This facility is part of the Sourasky Medical Center (Ichilov) in Tel Aviv. She gained international experience through practice at the City of Hope Hospital in Los Angeles. Additionally, she serves at various medical centers across Israel.
The doctor contributes to the medical community through research and speaking engagements. Her academic record includes:
She stays connected to clinical advancements through several professional organizations:
Dr. Selime Aydogdu is a specialist in pediatric hematology and oncology. She is known for her work in improving early cancer detection in children. Dr. Aydogdu has given many presentations and led discussions on recognizing early cancer symptoms. Her efforts have raised awareness in her field.
Her work has helped achieve better diagnostic results and higher survival rates for children. Dr. Aydogdu is dedicated to education and advocacy. She is a respected member of the pediatric oncology community.
Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.
He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.
He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.
His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.
Education:
2015
Dokuz Eylül University, Medical Faculty, Internal Medicine and Hematology
2010
Dokuz Eylül University, Medical Faculty, Internal Medicine
2005
Hacettepe University, Medical Faculty,
Experience:
2024 –
Istanbul Florence Nightingale Hospital
2017 – 2024
Bağcılar Medipol University Hospital
2017 – 2017
Fırat University
2015 - 2017
Fırat University
2014 - 2015
Mayo Clinic
Publications:
18 Articles Published in International Peer-Reviewed Journals
26 Abstracts and Books Presented at International Scientific Conferences
7 Articles Published in National Peer-Reviewed Journals
51 Abstracts Presented at National Scientific Conferences
Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.
She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.
She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.
She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.
Experience
Professional Memberships
Children's Hematologist. Specialist in bone marrow transplantation
イェシム・イルドゥルム教授は、80本以上の国際的な学術論文を発表している多産な研究者であり、免疫療法などの最新のがん治療を専門としています。
カンソイ教授はトルコで初めての小児骨髄移植ユニットを設立し、アナドル医療センターの小児腫瘍プログラムを率いています。
Dr. Francesc Cobo Valien graduated from the Faculty of Medicine of the University of Barcelona in 1990.
He received his specialization in oncohematology at the Hospital Clínic de Barcelona in 1995. He combined medical practice and research activities in the period 1996-2002.
He received his Doctor of Medicine degree from the University of Barcelona in 2002.
Dr. Kobo continues his research and has been awarded grants:
•Interdepartmental Commission for Innovation of the Generalitat de Catalunya
•Scholarship Fund Universitaria Agustí Pedro i Pons
•Farreras Valentí & Schering Plough School of Hematology Scholarship
•Award for the best report at the Council of the Spanish Hematology Association
•Grant from the Catalan Society of Hematology
Specialization:
•Lymphoma
•Acute leukemia
•Chronic leukemia
•Autoimmune pancytopenia
Medical Experience:
- 2024 - Present: Memorial Şişli Hospital
Specialist in Internal Medicine and Hematology / Istanbul
- 2017 - 2024: Istanbul Florence Nightingale Hospital
Specialist in Internal Medicine and Hematology / Istanbul
- 2015 - 2017: Eskişehir Yunus Emre State Hospital
Hematology Specialist - Compulsory Service / Eskişehir
Medical Education:
- 2020 - 2024: Istanbul Florence Nightingale Hospital
Demiroğlu Bilim University, Faculty of Medicine / Istanbul, Turkey
- 2017 - 2020: Istanbul Florence Nightingale Hospital
Demiroğlu Bilim University, Faculty of Medicine / Istanbul, Turkey
- 2011 - 2015: Eskişehir Osmangazi University, Faculty of Medicine, Department of Hematology / Eskişehir, Turkey
- 2009 - 2011: Harvard University, Faculty of Medicine / Boston, USA
- 2000 - 2008: Ankara University, Faculty of Medicine / Ankara, Turkey
- 1994 - 2000: Ankara University, Faculty of Medicine / Ankara, Turkey
Attended Professional Trainings, Courses, and Conferences:
- European Society for Blood and Marrow Transplantation, 3rd EBMT International Transplant Course, Barcelona, Course, 07.09.2018-09.09.2018 (International)
- Turkish Academy of Blood Science, Lymphoma Masterclass, Istanbul, Course, 01.09.2016-01.03.2017 (National)
- Advanced Life Support Course, Istanbul
Membership in Professional Associations:
- European Society for Blood and Marrow Transplantation
- Turkish Academy of Blood Science
- Advanced Life Support Course
| 順位 | 医師 | 経験 | 適合する方 | 特色 | クリニックと所在地 | 診察 |
|---|---|---|---|---|---|---|
| #1 | 49年の経験 | 骨髄移植 | トルコの骨髄移植センターを設立（MDアンダーソンがんセンターより招聘）。リンパ腫手術900件以上実施。米国血液学会（ASH）および欧州血液学会（EHA）会員。 | トルコ | から $280 | |
| #2 | 33年の経験 | 免疫療法および分子標的療法 | 腫瘍免疫学およびがん免疫療法を専門とし、進行期ホジキンリンパ腫症例において重要な役割を担う。主要医科大学の教授であり、40本以上の研究論文を発表している。 | トルコ | から $215 | |
| #3 | 22年の経験 | 免疫療法および分子標的療法 | 免疫療法などの先進的な治療に注力し、主要な腫瘍学の教科書を執筆している。ESMO認定資格を保有し、大学教授でもある。 | トルコ | から $215 | |
| #4 | 48年の経験 | 小児ホジキンリンパ腫 | 小児骨髄移植のパイオニアとして、トルコ初の移植ユニットを設立。EBMT認定施設長として、40年以上にわたり小児血液悪性腫瘍のみに専念してきた。 | トルコ | お問い合わせください | |
| #5 | 14年の経験 | 進行性ホジキンリンパ腫 | 免疫療法および分子診断を専門とする認定がんセンターを率いる。血液腫瘍学および遺伝学を専門とする研究者として論文を発表している。 | ドイツ | お問い合わせください |